It is possible that CLDN-2 may be highly expressed in the carcinogenesis of lung adenocarcinoma and LSR may be highly expressed in well-differentiated cancers and then may decrease in poorly differentiated cancers. This evidence concerns the gene CLDN2 and cancer.